What Is SS-31 Used For in Research?
SS-31 (Elamipretide) is a synthetic tetrapeptide widely investigated in preclinical research models for its ability to selectively target cardiolipin within the inner mitochondrial membrane. In laboratory settings, SS-31 is utilized to evaluate mitochondrial bioenergetics, attenuate reactive oxygen species generation, and preserve organelle ultrastructure across cellular, rodent, and ex vivo models of metabolic and oxidative stress.
Quick answer
SS-31 (Elamipretide) is a synthetic tetrapeptide widely investigated in preclinical research models for its ability to selectively target cardiolipin within the inner mitochondrial membrane. In laboratory settings, SS-31 is utilized to evaluate mitochondrial bioenergetics, attenuate reactive oxygen species generation, and preserve organelle ultrastructure across cellular, rodent, and ex vivo models of metabolic and oxidative stress.
Key takeaways
- In preclinical laboratory research, [SS-31](/research-peptides/ss-31) (also known as Szeto-Schiller 31 or Elamipretide) is primarily utilized to investigate mitochondrial dysfunction, oxidative stress pathways, and cellular bioenergetics.
- [SS-31](/research-peptides/ss-31) is a synthetic, water-soluble tetrapeptide with the amino acid sequence D-Arg-Dmt-Lys-Phe-NH2 (where Dmt represents 2',6'-dimethyltyrosine).
- In vitro models represent a major domain of [SS-31](/research-peptides/ss-31) research.
- Extending beyond single-cell cultures, researchers frequently employ [SS-31](/research-peptides/ss-31) in ex vivo organ preservation models to investigate methods for mitigating cold ischemia-reperfusion injury during transplantation research.
Direct Summary: Primary Preclinical Research Applications of SS-31
In preclinical laboratory research, SS-31 (also known as Szeto-Schiller 31 or Elamipretide) is primarily utilized to investigate mitochondrial dysfunction, oxidative stress pathways, and cellular bioenergetics. Because of its unique structural affinity for the inner mitochondrial membrane (IMM), researchers employ SS-31 in assays designed to quantify ATP yield, electron transport chain efficiency, and membrane potential preservation under cytotoxic or hypoxic conditions.
Investigators across cell biology, cardiology, and neurobiology utilize SS-31 to evaluate endpoints such as cardiolipin peroxidation, cytochrome c peroxidase activity, and cristae structural integrity. Across in vitro culture systems, ex vivo tissue preparations, and rodent disease models, the compound serves as a primary tool for probing how targeted IMM stabilization alters downstream inflammatory cascades, apoptotic signaling, and cellular survival mechanisms.
Molecular Architecture and Cardiolipin Binding Mechanism
SS-31 is a synthetic, water-soluble tetrapeptide with the amino acid sequence D-Arg-Dmt-Lys-Phe-NH2 (where Dmt represents 2',6'-dimethyltyrosine). Unlike un-targeted small-molecule antioxidants that diffuse non-specifically throughout the cytosol, SS-31 possesses an alternating aromatic-cationic motif that allows it to freely cross cell membranes and concentrate over 1,000-fold in the inner mitochondrial membrane independently of membrane potential.
The primary molecular target of SS-31 within the IMM is cardiolipin, an essential phospholipid exclusive to mitochondrial membranes. Cardiolipin interacts with respiratory complexes I, III, IV, and the ATP synthase to maintain optimal electron transport chain assembly and cristae curvature. Preclinical studies suggest that SS-31 electrostatically and hydrophobically binds to cardiolipin, preventing its oxidation by cytochrome c peroxidase complexes. By maintaining cardiolipin in a non-oxidized state, researchers observe preserved respiratory supercomplex assembly, optimized ATP synthesis, and reduced baseline generation of mitochondrial reactive oxygen species (mtROS).
In Vitro Research Models and Mitochondrial Bioenergetics Assays
In vitro models represent a major domain of SS-31 research. In cultured mammalian cells—including cardiomyocytes, renal tubular epithelial cells, primary neurons, and endothelial lineages—investigators introduce oxidative insults such as hydrogen peroxide, hypoxia-reoxygenation, or high glucose to model cellular injury.
Using extracellular flux analyzers (such as Seahorse XF instruments) and high-resolution respirometry (such as Oroboros O2k systems), laboratories measure oxygen consumption rate (OCR), basal respiration, maximal respiration, and spare respiratory capacity following treatment with research peptides like SS-31. In vitro data indicate that pre-treatment or concurrent administration of SS-31 prevents the collapse of mitochondrial membrane potential (ΔΨm) measured via fluorescent dyes such as JC-1 or TMRE, while concurrently suppressing mtROS production quantified via MitoSOX Red assays.
Ex Vivo and Extracorporeal Organ Preservation Research
Extending beyond single-cell cultures, researchers frequently employ SS-31 in ex vivo organ preservation models to investigate methods for mitigating cold ischemia-reperfusion injury during transplantation research. Isolated heart, kidney, and liver models perfused with physiological buffer solutions supplemented with SS-31 demonstrate reduced endothelial cell detachment, lower lipid peroxidation markers (such as malondialdehyde and 4-hydroxynonenal), and enhanced post-ischemic functional recovery.
These ex vivo protocols allow biomedical researchers to measure specific enzymatic markers of tissue damage, such as lactate dehydrogenase (LDH) release and creatine kinase (CK) efflux, directly attributing structural protection to the stabilization of cardiolipin microdomains during extended periods of hypoxia.
Rodent Models of Ischemia-Reperfusion and Cardioprotection
In vivo research utilizing rodent models provides crucial data regarding how SS-31 behaves in whole-organism physiological systems. In rodent models of acute myocardial infarction—typically induced by transient occlusion of the left anterior descending (LAD) coronary artery—researchers evaluate infarct size, cardiac remodeling, and inflammatory cell infiltration.
Preclinical studies report that animal models administered SS-31 during or immediately following ischemia demonstrate significant reductions in myocardial infarct size compared to vehicle controls. Mechanistic endpoints evaluated in these studies include reduced cleavage of caspase-3 and caspase-9, suppressed release of cytochrome c into the cytosol, and diminished transcription of pro-inflammatory cytokines such as TNF-alpha and IL-1beta in tissue homogenates.
Preclinical Models of Age-Related and Neurodegenerative Dysfunction
Mitochondrial decay is a well-established hallmark of neuromuscular degradation and cognitive decline in aging models. Consequently, researchers employ SS-31 in aged mouse and rat models to probe its effects on skeletal muscle energetics and neurodegenerative pathology.
In models of Amyotrophic Lateral Sclerosis (ALS), Alzheimer's disease, and Parkinson's disease, researchers measure parameters including alpha-synuclein aggregation, amyloid-beta accumulation, neuroinflammation, and motor performance. Animal study data suggest that targeting cardiolipin via SS-31 helps preserve synaptic mitochondrial density, maintains mitochondrial axonal transport rates, and reduces microglial activation within the central nervous system.
Comparative Analysis: SS-31, MOTS-c, and Humanin
When designing mitochondrial research studies, investigators frequently compare SS-31 against other peptide-based regulators of organelle function and metabolic homeostasis. Understanding the distinct mechanisms of action across these compounds is essential for selecting appropriate experimental endpoints.
While SS-31 functions primarily as a direct structural stabilizer of cardiolipin within the inner mitochondrial membrane, MOTS-c is a mitochondrial-derived peptide (MDP) that translocates to the nucleus under metabolic stress to regulate nuclear gene expression and systemic insulin sensitivity. Similarly, Humanin is an MDP that acts predominantly as a cytoprotective signal by binding extra-mitochondrial proteins like Bax and IGFBP-3 to inhibit apoptosis. While MOTS-c and Humanin modulate broad transcriptional and signaling cascades, SS-31 acts locally at the IMM membrane-lipid interface to maintain electron transport chain biophysics.
Reconstitution, Handling, and Laboratory Storage Parameters
Proper handling and solution preparation are vital to maintaining compound integrity during experimental protocols. Researchers receiving lyophilized SS-31 acetate should store the product at -20°C or -80°C in a desiccated environment to prevent moisture absorption and peptide degradation.
When preparing stock solutions for in vitro or in vivo administration, lyophilized SS-31 readily dissolves in sterile bacteriostatic water, phosphate-buffered saline (PBS, pH 7.4), or standard cell culture media. Laboratory personnel should utilize the reconstitution calculator to accurately determine solvent volumes and final molar concentrations. Avoid repeated freeze-thaw cycles by aliquoting reconstituted stock solutions into single-use microcentrifuge tubes prior to storage at -80°C.
Analytical Purity Verification and Quality Control Standards
To ensure reproducibility in quantitative research, investigators must utilize peptides subjected to rigorous analytical verification. Imprudent use of unverified reagents can introduce confounding factors—such as residual trifluoroacetate (TFA), organic solvents, or bacterial endotoxins—that alter mitochondrial membrane potential independently of the test compound.
Every lot of research-grade SS-31 manufactured for PX1 Research undergoes stringent quality control testing at an independent ISO 17025 accredited laboratory. Purity is validated using High-Performance Liquid Chromatography (HPLC) to guarantee a chemical purity threshold of ≥98%, while Mass Spectrometry (MS) confirms exact molecular mass. Furthermore, every batch is verified for low endotoxin levels (evaluated via LAL assay) to prevent non-specific immune activation in cell culture and animal models. Researchers can review batch-specific documentation directly via our public COA repository.
Frequently Asked Questions
What is the primary target of SS-31 in laboratory research?
SS-31 specifically targets and binds to cardiolipin, an essential phospholipid located exclusively in the inner mitochondrial membrane. This interaction prevents cardiolipin oxidation, maintains cristae architecture, and preserves electron transport chain efficiency.
How does SS-31 differ from non-targeted antioxidants in cellular assays?
Unlike non-targeted antioxidants that disperse non-specifically throughout the cytoplasm, SS-31 concentrates over 1,000-fold in the inner mitochondrial membrane due to its alternating aromatic-cationic structure, neutralizing reactive oxygen species at their primary site of production.
What solvents are recommended for reconstituting SS-31 for in vitro protocols?
SS-31 is highly water-soluble and can be reconstituted using sterile laboratory-grade water, phosphate-buffered saline (PBS, pH 7.4), or physiological saline. For cell culture experiments, stock solutions can be diluted directly into culture medium.
Is SS-31 suitable for human or veterinary administration?
No. SS-31 supplied by PX1 Research is strictly designated for laboratory research use only (RUO), including in vitro cellular assays, ex vivo tissue models, and preclinical animal research. It is not approved for human or veterinary diagnostic or therapeutic applications.
What parameters are verified on the PX1 Research COA for SS-31?
PX1 Research provides a lot-specific Certificate of Analysis (COA) generated by an independent ISO 17025 accredited laboratory. The COA verifies peptide purity (≥98% via HPLC), correct molecular mass (via Mass Spectrometry), and low endotoxin levels via kinetic LAL testing.
How should reconstituted SS-31 stock solutions be stored?
Reconstituted SS-31 stock solutions should be divided into single-use aliquots to prevent freeze-thaw degradation and stored at -80°C. Aliquots should be thawed immediately prior to use in assays.
What animal models are commonly used to study SS-31?
Researchers frequently investigate SS-31 in rodent models of myocardial ischemia-reperfusion, diabetic nephropathy, age-related sarcopenia, traumatic brain injury, and neurodegenerative disease models such as ALS and Alzheimer's disease.
Does SS-31 affect ATP production in uninjured control cells?
Preclinical studies indicate that SS-31 primarily optimizes bioenergetics under conditions of oxidative stress, hypoxia, or mitochondrial dysfunction, exhibiting minimal effect on baseline ATP production in normal, healthy control cells.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.